Liraglutide

Liraglutide is an acylated GLP-1 analogue studied as an agonist of the GLP-1 receptor. Laboratory research examines receptor binding, cyclic-AMP signaling, and the influence of lipid modification on peptide-protein interactions and stability. For laboratory research and analytical use only. Not intended for human or veterinary use, diagnosis, treatment, prevention, mitigation, or cure of any disease. No therapeutic or performance claims are made. Researchers are responsible for appropriate handling, institutional review, and compliance with all applicable laws and regulations.